The amendment, codified under document number 2025-24184, alters the Anti-Money Laundering/Countering the Financing of ...
The brokerage industry regulator cited gaps in surveillance, customer due diligence, and red-flag escalation across the ...
Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.
A detailed to-do list for SEC-registered firms to build a foundation for compliant and effective anti-money laundering ...
In financial institutions across the United States, there’s a reflex that’s become almost ritual. When a regulator walks in, or a board member asks whether the AML program is working, the answer is ...
Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program focused on acute myeloid leukemia ...
News-Medical.Net on MSN
Combination therapy offers hope for AML patients facing drug resistance
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...
SEATTLE, WA / ACCESS Newswire / June 18, 2025 / Aptevo Therapeutics ("Aptevo") (Nasdaq:APVO), a clinical-stage biotechnology company developing novel bispecific immuno-oncology therapeutics based on ...
– The Steering Committee brings together distinguished clinical experts in AML from leading National Comprehensive Cancer Network Centers – SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback